MLRT — Metalert Share News
0.000.00%
Last trade - 00:00- $0.01m
- $3.55m
- $0.18m
Ultragenyx's genetic disease treatment front-runner among rivals - Truist
Brief: GTX Corp Will Begin Selling Coronavirus Face Masks
Brief: Shipchain And GTX Corp Launch Global NFC Blockchain Shipment Tracking Solution
Brief: GTX Corp Announces Sale and Licensing of Patents and Technology to Inpixon
U.S. auto tech suppliers: Cycle headwinds continue - Jefferies
Brief: GTX Corp third quarter 2017 summary results
Brief: Inventergy Global announces definitive agreement with GTX